References
- Lieberman P, Patterson R, Kunske R. Complications of long-term steroid therapy for asthma. J Allergy Clin Immunol 1972; 49(6)329–336
- Blaiss M S, Herrod H G, Crawford L V, Lieberman P L. Beclomethasone dipropionate aerosol: Hematologic and immunologic effects. Ann Allergy 1982; 48: 210
- Smith M J, Hodson M E. Effects of long-term inhaled high-dose beclomethasone dipropionate on adrenal function. Thorax 1983; 38: 676–81
- Ebden P, Davies B H. High-dose corticosteroid inhalers for asthma. Lancet 1984; 2: 576
- Law C M, Marchant J L, Honour J W, Preece M A, Warner J O. Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate. Lancet 1986; 1: 942–4
- Jannings B H, Andersson K.-E, Johansson S.-A. Assessment of the systemic effects of inhaled glucocorticoids: the influence of blood sampling technique and frequency on plasma Cortisol and leucocytes. Eur J Clin Pharmacol 1990; 39: 127–131
- Prahl P. Adrenocortical suppression following treatment with beclomethasone and budesonide. Clin Exp Allergy 1991; 21: 145–146
- Fraunfelder F T, Meyer S M. Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids. Am J Ophthalmol 1990; 109(4)489–490
- Allen M B, Ray S G, Leitch A G, Dhillon B, Cullen B. Steroid aerosols and cataract formation. Br Med J 1989; 229: 432–433
- Capewell S, Reynolds S, Shuttleworth D, Edwards C, Finlay A Y. Purpura and dermal thinning associated with high-dose inhaled corticosteroids. Br Med J 1990; 300: 1548–1551
- Kruszynska Y T, Greenstone M A, Home P D, Cooke N J. Effect on high-dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects. Thorax 1987; 42: 881–884
- Hollman G A, Allen D B. Overt glucocorticoid excess due to inhaled corticosteroid therapy. Pediatrics 1988; 81: 452–455
- Wolff A H, Adelsberg B, Aloia J, Zitt M. Effect of inhaled corticosteroid on bone density in asthmatic patients: a pilot study. Ann Allergy 1991; 67: 117–121
- Toogood J H, Crilly R G, Jones G, Nadeau J, Wells G A. Effect on high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis. Am Rev Respir Dis 1988; 138: 57–61
- Teelucksingh S, Padfield P L, Tibi L, Gough K J, Holt P R. Inhaled corticosteroids, bone formation, and osteocalcin (letter). Lancet 1991; 338: 60–61
- Reid I R, Chapman G E, Fraser T RC, et al. Low serum osteocalcin levels in glucocorticoid-treated asthmatics. J Clin Endocrinol Metab 1986; 62: 379–83
- Reid D M, Nicoll J J, Smith M A, Higgins B, Tothill P, Nuki G. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J 1986; 293: 1463–1466
- Godrey S, Balfour-Lynn L, Tooley M. A three-to five-year follow-up of the use of the aerosol steroid, beclomethasone dipropionate, in childhood asthma. J Allergy Clin Immunol 1978; 62: 335–339
- Littlewood J M, Johnson A W, Edwards P A, Littlewood A E. Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet 1988; 1: 115–6
- Balfour-Lynn L. Growth and childhood asthma. Arch Dis Child 1986; 61: 1049–1055